PDBrown(@PDBrownOnc) 's Twitter Profile Photo

2ndCA/Dediff week 7/7
Do other treatments cause 2nd CA?
Danish study 910 patients lymphoma S/P high-dose chemotherapy and autologous HSCT
· 2nd CA rate higher than matched controls (HR 2·35).
· Cumulative risk 2nd CA at 10yrs 20%
thelancet.com/journals/lanha…

account_circle
Tom Donahue(@realtomd58) 's Twitter Profile Photo

All Things Multiple Sclerosis Research HSCT as a Frontline Therapy to stop MS in its tracks for 80% of MS Fighters.

Check out HSCTHope on Facebook to ask questions and engage with people who have gone through the Therapy.

HSCTHope.org

account_circle
Dr sanjeev(@drsanjeev1980) 's Twitter Profile Photo

PTCy is the black hole of HSCT, completely omitting everything , no one is going to escape, even in Matched sibling donor transplantation 🔥🔥

PTCy is the black hole of HSCT, completely omitting everything , no one is going to escape, even in Matched sibling donor transplantation 🔥🔥
account_circle
Fabio Pires(@fabiopss) 's Twitter Profile Photo

Summary: Postinduction molecular RT-PCR MRD for NPM1 mutation is the most impt biomarker in NPM1-mut AML that should guide decision to proceed to Allo-HSCT in 1st CR

ashpublications.org/blood/article/…

Summary: Postinduction molecular RT-PCR MRD for NPM1 mutation is the most impt biomarker in NPM1-mut AML that should guide decision to proceed to Allo-HSCT in 1st CR #leusm #AML

ashpublications.org/blood/article/…
account_circle
Southern Trust(@SouthernHSCT) 's Twitter Profile Photo

What goes on inside our hospital pharmacy? 💊
Today we welcomed almost 80 people to our department in Craigavon Area Hospital to experience all things pharmacy - whether that be the role of an assistant, technician or clinical pharmacist.
pulse.ly/ithkwq11im

What goes on inside our hospital pharmacy? 💊
Today we welcomed almost 80 people to our department in Craigavon Area Hospital to experience all things pharmacy - whether that be the role of an assistant, technician or clinical pharmacist.
pulse.ly/ithkwq11im
#TeamSHSCT
account_circle
Andre-ACGT(@Andre_AGTC) 's Twitter Profile Photo

$RCKT
Long-term KRESLADITM demonstrate survival of 100% in the absence of allogeneic HSCT from 18 to 45 mo with a well-tolerated safety in all 9 ptnts with severe LAD-I
Their LV portfolio is doing (surprisingly) well

account_circle
Top Biomedical Science(@imedverse) 's Twitter Profile Photo

These results provide evidence for the clinical relevance of including genomic features into the transplantation decision making process, allowing personalizing the hazards and effectiveness of HSCT in patients with MDS. Journal of Clinical Oncology ASCO ESMO - Eur. Oncology OncoAlert @OncoDaily

These results provide evidence for the clinical relevance of including genomic features into the transplantation decision making process, allowing personalizing the hazards and effectiveness of HSCT in patients with MDS. @JCO_ASCO @ASCO @myESMO @OncoAlert @OncoDaily #Oncology
account_circle
Carmelo Gurnari(@CarmeloGurnari) 's Twitter Profile Photo

It’s MDS and HSCT week!!!🤩 off the press in Blood Journal 👉Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms? ashpublications.org/blood/article-…

It’s MDS and HSCT week!!!🤩 off the press in @BloodJournal 👉Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms? ashpublications.org/blood/article-…
account_circle
Carlos M. Peñate, MD(@Carlos_Penate6) 's Twitter Profile Photo

◾️Specific anticancer treatment proven to have high risk of long term CV complications:
•Doxorubicin >250mg/m2
•RT>15 Gy MHD
•Both doxorubicin >100mg/m2 and RT 5-15 Gy MHD
•High-risk HSCT patients

🫀

account_circle
Christian Le Bracq(@chrisfrom56) 's Twitter Profile Photo

Please help me raise any amount towards £40,000 for my daughter's HSCT treatment, which could halt the progression of her MS. The NHS has declined to offer her this treatment, opting instead to provide medication !
justgiving.com/crowdfunding/c…

Please help me raise any amount towards £40,000 for my daughter's HSCT treatment, which could halt the progression of her MS. The NHS has declined to offer her this treatment, opting instead to provide medication !  #bigpharmasucks
justgiving.com/crowdfunding/c…
account_circle
Na Azmin(@helwana_na) 's Twitter Profile Photo

Navitating the Transplant Journey: A Guide for Nurses.
Alhamdulillah.. setahun perjalanan penghasilan buku ni.
Semoga bermanfaat

Navitating the Transplant Journey: A Guide for Nurses. 
Alhamdulillah.. setahun perjalanan penghasilan buku ni. 
Semoga bermanfaat 
#nurse #transplant #hsct #HappyNursesWeek
account_circle
Eliisa Kekäläinen(@lettipitko) 's Twitter Profile Photo

New publication out in ⁦ICB - the journal⁩ 🥳. We studied a cohort of pediatric recipients of allo from ⁦HUS Helsingin yliopistollinen sairaala⁩ over 2 yrs after the transplantation. We used ⁦Olink Proteomics⁩ to look for soluble biomarkers of inflammation, tiny🧵 onlinelibrary.wiley.com/doi/10.1111/im…

account_circle
AmericanJournalofHematology(@AjHematology) 's Twitter Profile Photo

2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management doi.org/10.1002/ajh.27…

2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management doi.org/10.1002/ajh.27…
#stemcelltransplant #HSCT #mpnsm
account_circle
Masayuki Umeda M.D., Ph.D. (梅田雅之)(@masayuki_umeda_) 's Twitter Profile Photo

先月出たNEJMの論文。CD7陽性白血病に対してCD7 CAR-T療法を行いそのまま造血幹細胞移植を行う事で、前処置もGVHD予防も不要なプロトコールだそう。

Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis | New England Journal of Medicine nejm.org/doi/full/10.10…

account_circle
Joaquim Vives(@xinoxan) 's Twitter Profile Photo

📢 cells can be useful in the treatment of patients with post- who are not responding to other options.
💡If interested, please read our latest paper:
🔗doi.org/10.3389/fped.2…

📢#Allogeneic #Mesenchymal cells can be useful in the treatment of patients with #complications post-#HSCT who are not responding to other #treatment options. 
💡If interested, please read our latest paper:
🔗doi.org/10.3389/fped.2…
account_circle